Why did UBS upgrade Solstice Advanced Materials to Buy, and what growth metrics support this decision?

UBS upgraded Solstice Advanced Materials Inc. (NASDAQ: SOLS) to Buy from Neutral due to an improved financial mix following the ESI deal and its projection of 'mid-teens-plus earnings per share growth'. Specifically, the firm expects approximately 18% EPS growth and over 10% annual EBITDA growth, which underpin its positive outlook and belief that the stock could rise over 25% in the next year—even independent of the deal's progression.

What is UBS's current price target for Solstice Advanced Materials, and how does it compare to the previous one?

UBS lowered its price target for Solstice Advanced Materials to $78.00 from $88.00, yet still sees significant upside potential—citing expectations of over 25% stock appreciation in the next year—and notes recent positive EPS results and increased analyst price targets from BMO Capital as supporting factors.

UBS Upgrades Solstice Advanced Materials Stock Rating on Growth Outlook

Jul 13, 2026

UBS upgraded Solstice Advanced Materials to Buy from Neutral, citing improved financials post-ESI deal and projecting mid-teens EPS growth. Despite a lower price target of $78, the firm expects over 25% upside driven by strong EBITDA expansion.

Investing.com South Africa

UBS Upgrades Solstice Advanced Materials Stock Rating on Growth Outlook

Investing.com Nigeria

2026-06-08

Truist Initiates Solstice Advanced Materials Stock Coverage with Hold Rating

2026-06-09

Truist Financial Initiates Solstice Advanced Materials (SOLS.US) With Hold Rating, Announces Target Price $90

2026-06-24

BMO Capital Maintains Solstice Advanced Materials (SOLS.US) With Buy Rating, Maintains Target Price $101

2026-06-26

Solstice Advanced Materials Inc. Actuals & Estimates (NASDAQ: SOLS)